Showing results (151-160 of 213) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Efficacy of systemically administered mutant vesicular stomatitis virus (VSVDelta51) combined with radiation for nasopharyngeal carcinomaNehad M Alajez, Joseph D Mocanu, Wei Shi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 16, 2015
Phase 1b Trial of Biweekly Intravenous Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus in Colorectal CancerSe Hoon Park, Caroline J Breitbach, Jeeyun Lee, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Oncolytic Maraba virus MG1 mediates direct and natural killer cell-dependent lysis of Ewing sarcomaTyler Barr, Victoria A Jennings, Elizabeth A Roundhill, et al.
Oncoimmunology|December 8, 2018
Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumorsJonathan G Pol, Sarah Lévesque, Samuel T Workenhe, et al.
Molecular Therapy Oncolytics|August 21, 2019
Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer TherapyAdrian Pelin, Johann Foloppe, Julia Petryk, et al.
Cancers|October 29, 2025
Oncolytic Maraba Virus MG1 Mediates Direct and Natural Killer Cell-Dependent Lysis of Ewing SarcomaTyler Barr, Victoria A Jennings, Elizabeth A Roundhill, et al.
Plos One|July 19, 2016
Correction: Surgical Stress Abrogates Pre-Existing Protective T Cell Mediated Anti-Tumor Immunity Leading to Postoperative Cancer RecurrenceAbhirami A Ananth, Lee-Hwa Tai, Casey Lansdell, et al.
Cancer Cell|October 31, 2003
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agentsDavid F Stojdl, Brian D Lichty, Benjamin R tenOever, et al.
Plos One|May 20, 2016
Surgical Stress Abrogates Pre-Existing Protective T Cell Mediated Anti-Tumor Immunity Leading to Postoperative Cancer RecurrenceAbhirami A Ananth, Lee-Hwa Tai, Casey Lansdell, et al.
Oncogene|May 13, 2020
Loss of the Ste20-like kinase induces a basal/stem-like phenotype in HER2-positive breast cancersKhalid N Al-Zahrani, John Abou-Hamad, David P Cook, et al.
Pageof 22